CSPC Pharmaceutical Group Limited

BMV:1093 N Stock Report

Market Cap: Mex$151.7b

CSPC Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BMV:1093 N Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Dec 24BuyMex$12,431,713Dongchen CaiIndividual1,000,000Mex$12.43
13 Dec 24BuyMex$12,431,713Dongchen CaiIndividual1,000,000Mex$12.43
27 Nov 24BuyMex$6,498,982Dongchen CaiIndividual484,000Mex$13.43
26 Nov 24BuyMex$5,410,604Dongchen CaiIndividual400,000Mex$13.53
25 Nov 24BuyMex$13,283,648Dongchen CaiIndividual1,000,000Mex$13.28
22 Nov 24BuyMex$13,558,582Dongchen CaiIndividual1,000,000Mex$13.56
21 Nov 24BuyMex$2,727,952Dongchen CaiIndividual200,000Mex$13.64
19 Nov 24BuyMex$5,319,480Dongchen CaiIndividual400,000Mex$13.30
09 Sep 24BuyMex$11,763,775Dongchen CaiIndividual1,000,000Mex$11.76
29 Aug 24BuyMex$12,250,370Dongchen CaiIndividual1,000,000Mex$12.25
29 Aug 24BuyMex$2,420,014Hao JiangIndividual200,000Mex$12.10
28 Aug 24BuyMex$20,103,504Dongchen CaiIndividual1,700,000Mex$11.83
28 Aug 24SellMex$119,155,494BlackRock, Inc.Company10,016,000Mex$11.90
26 Aug 24BuyMex$9,505,303Dongchen CaiIndividual800,000Mex$11.88
23 Aug 24BuyMex$13,931,379Dongchen CaiIndividual1,200,000Mex$11.61
22 Aug 24BuyMex$16,747,127Dongchen CaiIndividual1,378,000Mex$12.15
22 Aug 24BuyMex$12,189,323Cuilong ZhangIndividual1,000,000Mex$12.19
21 Mar 24SellMex$90,567,598UBS Asset Management AGCompany6,584,000Mex$13.76

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1093 N?
Owner TypeNumber of SharesOwnership Percentage
Private Companies755,676,3136.38%
Individual Insiders2,806,223,35023.7%
Institutions3,670,809,78031%
General Public4,616,046,28939%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 55.84% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
23.6%
Dongchen Cai
2,799,375,670Mex$35.8b0%no data
6.15%
Common Success International Limited
728,796,313Mex$9.3b0%no data
5.97%
UBS Asset Management AG
707,752,096Mex$9.1b-9.09%0.08%
4.91%
BlackRock, Inc.
581,995,297Mex$7.5b-0.35%0.01%
2.94%
The Vanguard Group, Inc.
348,328,571Mex$4.5b0.06%no data
1.97%
First Sentier Investors (Australia) IM Ltd
233,308,401Mex$3.0b6.79%0.44%
1.13%
Norges Bank Investment Management
133,557,948Mex$1.7b0%0.01%
1.12%
State Street Global Advisors, Inc.
132,470,607Mex$1.7b2.98%no data
0.92%
Bosera Asset Management Co., Ltd.
108,516,000Mex$1.4b0%0.47%
0.89%
Dimensional Fund Advisors LP
105,370,128Mex$1.3b3.77%0.01%
0.72%
abrdn plc
85,183,122Mex$1.1b11.4%0.05%
0.6%
Caisse de dépôt et placement du Québec
70,568,837Mex$903.5m0%0.06%
0.57%
Hang Seng Investment Management Limited
67,496,395Mex$864.1m-1.99%0.59%
0.57%
Harvest Fund Management Co. Ltd.
67,478,040Mex$863.9m0%0.18%
0.52%
Zhong Ou Fund Management Co., Ltd
61,914,000Mex$792.7m0%0.19%
0.45%
RBC Global Asset Management Inc.
53,282,009Mex$682.1m-0.4%0.03%
0.42%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
49,874,423Mex$638.5m-26.6%0.01%
0.39%
China Asset Management Co. Ltd.
46,143,235Mex$590.8m0.37%0.06%
0.36%
GF Fund Management Co., Ltd.
42,510,000Mex$544.2m0%0.08%
0.34%
Amundi Asset Management SAS
40,049,600Mex$512.7m-14.2%0.01%
0.33%
Geode Capital Management, LLC
38,760,549Mex$496.2m3.73%no data
0.28%
UBS SDIC Fund Management Co., Ltd.
33,426,640Mex$427.9m0%0.54%
0.23%
Credit Suisse Asset Management (Switzerland) Ltd.
27,687,141Mex$354.5m2.32%0.02%
0.23%
Massive Top Limited
26,880,000Mex$344.1m0%no data
0.22%
Eastspring Investments (Singapore) Limited
25,498,800Mex$326.4m0%0.08%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/02/12 16:54
End of Day Share Price 2023/11/15 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CSPC Pharmaceutical Group Limited is covered by 50 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wai Chak YuenBOCI Research Ltd.
Sharon ShiBOCI Research Ltd.
Ethan CuiBofA Global Research